Equity Overview
Price & Market Data
Price: $1.17
Daily Change: $0.00 / 0.00%
Range: $1.13 - $1.17
Market Cap: $5,122,072
Volume: 760
Performance Metrics
1 Week: -5.65%
1 Month: 4.46%
3 Months: -17.02%
6 Months: -87.42%
1 Year: -84.27%
YTD: -86.78%
Company Details
Employees: 6
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases. It develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-101, an IL13Ra2 CAR T cell program for glioblastoma; and MB-108 for the treatment of herpes simplex virus-1 oncolytic virus C134. The company was incorporated in 2015 and is headquartered in Waltham, Massachusetts.